Domov › Rak trebušne slinavke › Illinois › Chicago
Klinične študije za Rak trebušne slinavke v Chicago, IL
20 študij za Rak trebušne slinavke išče udeležence na lokacijah v Chicago in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Research Site, Chicago
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Vključevanje udeležencevFaza 3
- City of Hope, Chicago
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Vključevanje udeležencevFaza 1
- Northwestern University, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- University of Chicago Hospital, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- University of Illinois Cancer Center, Chicago
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Vključevanje udeležencevFaza 3
- University of Chicago Medical Center, Chicago
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Vključevanje udeležencevFaza 3
- Investigative Site US079, Chicago
CREO - Microwave Ablation Feasibility Study
Vključevanje udeležencev
- Rush University Medical Center, Chicago
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Vključevanje udeležencevOpazovalna študija
- Northwestern University, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Vključevanje udeležencevFaza 1/2
- Northwestern University, Chicago
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Vključevanje udeležencevFaza 3
- Northwestern University, Chicago
- University of Illinois, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Pancreatic Cancer Early Detection Consortium
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- University of Chicago Medicine, Chicago
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Vključevanje udeležencevFaza 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Vključevanje udeležencevFaza 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
Lidocaine Infusion in Pancreatic Cancer
Vključevanje udeležencevZgodnja faza 1
- University of Illnois at Chicago, Chicago
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Vključevanje udeležencevFaza 3
- Northwestern University, Chicago
- University of Illinois, Chicago
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Vključevanje udeležencevFaza 2
- Ohio State University-Telemedicine, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Vključevanje udeležencevOpazovalna študija
- Advocate Illinois Masonic Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Vključevanje udeležencevFaza 2
- Northwestern University, Chicago
Študije za Rak trebušne slinavke v drugih mestih
- Houston, TX61 študij
- New York City, NY60 študij
- Boston, MA43 študij
- Nashville, TN39 študij
- Los Angeles, CA35 študij
- St. Louis, MO33 študij
- Arlington, VA33 študij
- Baltimore, MD31 študij
- San Antonio, TX31 študij
- Philadelphia, PA26 študij
- Tampa, FL26 študij
- Durham, NC24 študij
Druge študije v Chicago
- Nemalicelični pljučni rak61 študij
- Rak dojke59 študij
- Rak (vse vrste)51 študij
- Metastatski rak45 študij
- Rak prostate45 študij
- Rak pljuč41 študij
- Debelost41 študij
- Rak jajčnikov36 študij
- Kolorektalni rak34 študij
- Možganska kap34 študij
- Srčno popuščanje31 študij
- Prekomerna telesna teža29 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.